UC San Diego researchers identify new strategy to improve efficacy of immunotherapy on resistant liver cancers.
UC San Diego School of Medicine partners with The Michael J. Fox Foundation on a clinical study to identify biomarkers of Parkinson’s disease. The study seeks to recruit 4,000 participants by the end of 2023.
On Saturday, Dec. 4, a total eclipse of the sun will occur at 07:33 (Universal Time) over Antarctica and parts of the South Pacific near the southern tip of Chile. The solar corona – visible to the naked eye only during a total eclipse – will be viewable for just over one minute.
Researchers report that an abbreviated, seven-item scale can help determine with high validity a person’s level of wisdom, a potentially modifiable personality trait that has been shown to have a strong association to well-being.
As a heart fails, a woman's ventricular wall increases in thickness relative to a man's. And in heart valve disease, men show more calcified tissue growth, while women develop more fibrotic, scar-like tissue. Yet, treatments for both diseases remain strikingly similar for both men and women, despite…
The San Diego Supercomputer Center has a new director. Frank Würthwein, lead of SDSC’s Distributed High-Throughput Computing Group, executive director of the Open Science Grid, a physics professor and a founding faculty member of the Halıcıoğlu Data Science Institute at UC San Diego assumes the…
UC San Diego nanoengineers developed a new and potentially more effective way to deliver messenger RNA (mRNA) into cells. Their approach involves packing mRNA inside nanoparticles that mimic the flu virus—a naturally efficient vehicle for delivering genetic material such as RNA inside cells.
Scott Lippman, MD, will lead the PreCancer Genome Atlas, an NCI-sponsored effort to map premalignant lesions and how they evolve into invasive cancers.
Novel randomized controlled trial found that families with high consumption of avocados experienced reduced caloric intake and an overall healthier diet, without actually changing their diet.
The California Institute for Regenerative Medicine (CIRM) approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen receptor (CAR) T-cell therapy from the laboratory into the clinic.